FFCP PHASE1:Mm9::chr6:50347067..50347076,-: Difference between revisions
From FANTOM5_SSTAR
No edit summary |
No edit summary |
||
Line 1: | Line 1: | ||
{{FFCP|EntrezGene=71720|HGNC=|MCL_coexpression_id=11|UniProt=|association_with_transcript=74bp_to_ENSMUST00000136926_5end|description=CAGE_peak_13_at_Osbpl3_5end|id=chr6:50347067..50347076,-|ontology_enrichment_celltype=|ontology_enrichment_celltype_v019_2=|ontology_enrichment_disease=|ontology_enrichment_disease_v019_2=|ontology_enrichment_uberon=UBERON:0002113!4.06e-25!14;UBERON:0003918!4.06e-25!14;UBERON:0005095!4.06e-25!14;UBERON:0007687!4.06e-25!14;UBERON:0006554!5.38e-22!16;UBERON:0001008!1.04e-20!17;UBERON:0000489!8.83e-17!21;UBERON:0003103!3.53e-08!43;UBERON:0005172!3.66e-07!49;UBERON:0005173!3.66e-07!49;UBERON:0002417!3.66e-07!49;UBERON:0000916!3.66e-07!49|ontology_enrichment_uberon_v019_2=UBERON:0002113,1.46e-25,14;UBERON:0003918,1.46e-25,14;UBERON:0011143,1.46e-25,14;UBERON:0005095,1.46e-25,14;UBERON:0007687,1.46e-25,14;UBERON:0006554,4.16e-20,18;UBERON:0001008,4.22e-19,19;UBERON:0000489,2.25e-17,21;UBERON:0003103,6.31e-09,43;UBERON:0005172,6.29e-08,49;UBERON:0005173,6.29e-08,49;UBERON:0002417,6.29e-08,49;UBERON:0000916,6.29e-08,49|phase1_expression=0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.255129870453209,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.34255163915718,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.203651327845314,0,0.210407459670956,1.07502113111237,1.18088118383682,2.98297582898612,2.71473760627961,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.214871054048298,0,0,0|short_description=p13@Osbpl3}} | {{FFCP | ||
|DHSsupport=NA | |||
|DPIdataset=NA | |||
|EntrezGene=entrezgene:71720 | |||
|HGNC= | |||
|MCL_coexpression_id=11 | |||
|TSSclassifier=NA | |||
|UniProt= | |||
|association_with_transcript=74bp_to_ENSMUST00000136926_5end | |||
|cluster_id=chr6:50347067..50347076,- | |||
|description=CAGE_peak_13_at_Osbpl3_5end | |||
|id=chr6:50347067..50347076,- | |||
|ontology_enrichment_celltype= | |||
|ontology_enrichment_celltype_v019_2= | |||
|ontology_enrichment_disease= | |||
|ontology_enrichment_disease_v019_2= | |||
|ontology_enrichment_uberon=UBERON:0002113!4.06e-25!14;UBERON:0003918!4.06e-25!14;UBERON:0005095!4.06e-25!14;UBERON:0007687!4.06e-25!14;UBERON:0006554!5.38e-22!16;UBERON:0001008!1.04e-20!17;UBERON:0000489!8.83e-17!21;UBERON:0003103!3.53e-08!43;UBERON:0005172!3.66e-07!49;UBERON:0005173!3.66e-07!49;UBERON:0002417!3.66e-07!49;UBERON:0000916!3.66e-07!49 | |||
|ontology_enrichment_uberon_v019_2=UBERON:0002113,1.46e-25,14;UBERON:0003918,1.46e-25,14;UBERON:0011143,1.46e-25,14;UBERON:0005095,1.46e-25,14;UBERON:0007687,1.46e-25,14;UBERON:0006554,4.16e-20,18;UBERON:0001008,4.22e-19,19;UBERON:0000489,2.25e-17,21;UBERON:0003103,6.31e-09,43;UBERON:0005172,6.29e-08,49;UBERON:0005173,6.29e-08,49;UBERON:0002417,6.29e-08,49;UBERON:0000916,6.29e-08,49 | |||
|phase1_expression=0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.255129870453209,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.34255163915718,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.203651327845314,0,0.210407459670956,1.07502113111237,1.18088118383682,2.98297582898612,2.71473760627961,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.214871054048298,0,0,0 | |||
|short_description=p13@Osbpl3 | |||
}} |
Revision as of 21:49, 5 August 2015
Short description: | p13@Osbpl3 |
---|---|
Species: | Mouse (Mus musculus) |
DPI dataset: | NA |
TSS-like-by-RIKEN-classifier(Yes/No): | NA |
DHS support(Yes/No): | NA |
Description: | CAGE_peak_13_at_Osbpl3_5end |
Coexpression cluster: | MCL_coexpression_mm9:11 |
Association with transcript: | 74bp_to_ENSMUST00000136926_5end |
EntrezGene: | 71720 |
Link to Zenbu: | ZENBU |
View on UCSC genome browser
CAGE Expression
- Click each plot point to find sample in table
Ontology-based sample term enrichment analysis<b>Summary:</b>This analysis has been performed by utilizing wilcoxon rank sum test.When the number of associated cells/tissues are > n , randomly sampled n cells/tissues are used for P value calculation with rank sum test. this process are repeated several times, and the P values are averaged on the log space <br><b>Analyst:</b> Hideya Kawaji<br><br>link to source dataset<br>data
Ontology term | p-value | n |
---|---|---|
kidney | 1.46e-25 | 14 |
kidney mesenchyme | 1.46e-25 | 14 |
upper urinary tract | 1.46e-25 | 14 |
kidney rudiment | 1.46e-25 | 14 |
kidney field | 1.46e-25 | 14 |
urinary system structure | 4.16e-20 | 18 |
renal system | 4.22e-19 | 19 |
cavitated compound organ | 2.25e-17 | 21 |
compound organ | 6.31e-09 | 43 |
abdomen element | 6.29e-08 | 49 |
abdominal segment element | 6.29e-08 | 49 |
abdominal segment of trunk | 6.29e-08 | 49 |
abdomen | 6.29e-08 | 49 |